Understanding GLP-1 Agonists: The ‘Weight Loss’ Drugs Taking the World by Storm
Risk & Insurance - May 12, 2025
GLP-1 agonist drugs are designed to treat type 2 diabetes, but their secondary weight loss effect is driving popularity. The post Understanding GLP-1 Agonists: The ‘Weight Loss’ Drugs Taking the World by Storm appeared first on Risk & Insurance. ...
Recommended Articles
Posted: Apr 01, 2026
Construction costs for a single data center location can exceed $20 billion — double once technology...
Posted: Apr 01, 2026
The American Society of Safety Professionals identified five themes reshaping workplace safety, incl...
Posted: Apr 01, 2026
A new Munich Re report finds that ransomware, supply chain attacks and AI-driven threats are expandi...